查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2047927

腫瘤醫療器材市場－全球產業規模、佔有率、趨勢、機會、預測：按類型、應用、地區和競爭格局分類，2021-2031年

Tumor Treatment Equipment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 188 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球腫瘤治療設備市場（包括用於標靶破壞和治療惡性腫瘤的放射治療系統和熱消融設備等專用醫療設備）預計將大幅擴張。

2025年，該市場價值為142.3億美元，預計到2031年將達到208.7億美元，複合年成長率預計為6.59%。這一成長主要受全球癌症發病率上升以及對有效治療方法以提高患者生存率的需求不斷成長的推動。

市場概覽
預測期 2027-2031
市場規模：2025年 142.3億美元
市場規模：2031年 208.7億美元
複合年成長率：2026-2031年 6.59%
成長最快的細分市場 放射治療設備
最大的市場 北美洲

癌症負擔日益加重，迫使醫療機構加強治療能力。例如，美國癌症協會預測，到2025年，美國將新增約2,041,910例癌症病例，凸顯了對先進腫瘤治療的巨大需求。然而，市場擴張的一大障礙是引進和維護尖端治療技術所需的大量資金投入。這些高昂的引進和安裝成本，加上必須遵守嚴格的監管規定，往往限制了此類設備在中低收入地區和小規模醫療機構的使用，阻礙了最新腫瘤治療方案的廣泛應用，儘管臨床需求顯而易見。

市場促進因素

推動市場發展的關鍵因素之一是將人工智慧 (AI) 和機器學習技術融入治療計劃，這顯著提高了全球腫瘤治療設備的精確度。先進的演算法使臨床醫生能夠精確地可視化腫瘤輪廓，從而最大限度地減少周圍健康組織的輻射暴露，並在複雜病例中最佳化劑量傳遞。這項技術進步不僅改善了臨床療效，也簡化了工作流程。各國政府和醫療機構正在投資這些自動化系統，以應對日益成長的患者數量。

例如，2025年2月，英國政府宣布撥款8,260萬英鎊，用於一項利用人工智慧診斷和治療癌症的計畫。同時，醫療保健支出的成長和基礎設施的改善也推動了新型放射治療和消融系統的應用。各國正在投入更多資金用於醫院設施現代化改造和採購高通量治療設備，以應對日益沉重的癌症負擔，使醫療機構能夠用符合標準的線性加速器和質子治療設備替換過時的設備。這些資金投入已反映在市場上。西門子健康保險公司報告稱，受設備需求的推動，其「先進治療」業務部門在2025年11月實現了3.8%的同比成長。 Elekta公司也報告稱，到2025年，全球將部署超過7500台設備，這表明治療基礎設施正在不斷擴展。

市場挑戰

全球腫瘤治療設備市場面臨的一大挑戰是，引進和維護高階治療技術都需要龐大資本投入。這些先進設備的前期成本往往超出小規模醫療機構的承受能力，尤其是在中低收入地區。這種經濟負擔將基本客群限制在經濟富裕的都市區，從而形成瓶頸，阻礙了關鍵治療基礎設施的廣泛應用。

因此，當醫療機構無法獲得充足資金或預期投資回報時，這些關鍵治療設備的部署往往會被推遲或取消，直接導致潛在市場規模縮小。營運收入的下降進一步加劇了這種財務負擔，使得醫療中心越來越難以收回資本投資。對長期盈利的不確定性迫使醫院延長老舊設備的使用壽命，而不是投資新系統。例如，美國放射腫瘤學會指出，到2025年，聯邦醫療保險（Medicare）的報銷金額將大幅下降，加劇了過去十年累積23%的降幅。這種財務不穩定直接阻礙了市場成長，因為它限制了醫療機構為部署最先進的癌症治療設備及其維護（以符合複雜的法規）提供資金的能力。

市場趨勢

市場的一個關鍵趨勢是質子和粒子治療中心的擴張。這反映出人們正朝著提供高精度、低劑量輻射的放射治療方向發展，尤其有利於兒童癌症和複雜的中樞神經系統（CNS）腫瘤的治療。這一趨勢包括建造配備迴旋加速器以產生帶電粒子的專用設施，與傳統的基於光子的治療系統相比，迴旋加速器能夠提供更優異的劑量適形性。儘管對基礎設施的要求很高，但醫療網路正在積極擴展其能力，以將這種療法作為標準治療方案。

例如，2025年4月，賓州大學醫學中心斥資2.24億美元興建新的質子治療中心，旨在提升其系統內先進粒子束療法的普及程度。同時，機器人輔助腫瘤手術平台的普及正在革新腫瘤切除術，透過提高手術可及性和視野清晰度，實現微創手術。這些平台使外科醫生即使在有限的解剖區域內也能進行複雜的切除術，從而顯著縮短癌症患者的術後恢復時間和住院時間。隨著臨床應用從泌尿系統擴展到胸腔外科和一般外科腫瘤學，市場接受度持續成長。例如，2025年10月，直覺外科公司報告稱，其全球手術量較上年成長約20%，全球機器人系統部署量達10,763套。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球腫瘤醫療器材市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依類型（外科手術設備、放射治療設備、化療設備）
    • 依應用領域（肺癌、大腸癌、乳癌、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美腫瘤醫療器材市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲腫瘤醫療器材市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區腫瘤醫療器材市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲腫瘤醫療器材市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美腫瘤醫療器材市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章 全球腫瘤醫療器材市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Boston Scientific Corp
  • Medtronic plc.
  • Johnson & Johnson
  • Merit Medical Inc.
  • Varian Medical Inc.
  • AngioDynamics Inc.
  • HealthTronics Inc.
  • SonaCare Medical LLC
  • Misonix Inc.
  • CAScination AG

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 18787

The global market for tumor treatment equipment, which includes specialized medical devices like radiotherapy systems and thermal ablation units used for the targeted destruction and management of malignant neoplasms, is projected to expand significantly. Valued at USD 14.23 Billion in 2025, it is expected to reach USD 20.87 Billion by 2031, demonstrating a Compound Annual Growth Rate (CAGR) of 6.59%. This growth is primarily fueled by the increasing global incidence of cancer, which drives the demand for effective therapeutic approaches to enhance patient survival rates.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 14.23 Billion
Market Size 2031USD 20.87 Billion
CAGR 2026-20316.59%
Fastest Growing SegmentRadiotherapy Equipment
Largest MarketNorth America

This rising burden of cancer compels healthcare providers to bolster their treatment capabilities; for instance, the American Cancer Society projected approximately 2,041,910 new cancer cases in the United States for 2025, highlighting a substantial need for advanced oncological care. However, a major impediment to market expansion is the considerable capital investment necessary for procuring and maintaining high-end treatment technologies. These high acquisition and installation costs, along with stringent regulatory compliance, frequently limit the availability of these devices in low-to-middle-income regions and smaller healthcare settings, thus hindering the broad adoption of modern tumor treatment solutions despite the clear clinical demand.

Market Driver

A key market driver is the integration of Artificial Intelligence (AI) and Machine Learning into treatment planning, which significantly boosts the precision of tumor treatment equipment globally. Advanced algorithms allow clinicians to precisely contour tumors, thereby minimizing radiation exposure to healthy tissues nearby and optimizing dose delivery for intricate cases. This technological advancement not fetches only enhances clinical outcomes but also improves workflow efficiency, leading governments and institutions to invest in these automated systems to manage growing patient numbers.

For example, the UK government announced £82.6 million in funding in February 2025 for projects leveraging AI to diagnose and treat cancer. Simultaneously, increasing healthcare expenditure and infrastructure development are propelling the acquisition of new radiotherapy and ablation systems. Nations are allocating more capital to modernize hospital facilities and procure high-throughput treatment devices to address the rising cancer burden, enabling healthcare providers to replace outdated equipment with compliant linear accelerators and proton therapy units. This financial commitment is reflected in the market, with Siemens Healthineers reporting 3.8% comparable revenue growth in its Advanced Therapies segment in November 2025 due to equipment demand, and Elekta reporting an installed base of over 7,500 devices globally in 2025, showcasing expanding treatment infrastructure.

Market Challenge

A significant challenge for the Global Tumor Treatment Equipment Market is the prohibitive capital investment required for both acquiring and maintaining high-end treatment technologies. The substantial upfront costs associated with these advanced devices frequently surpass the financial capabilities of smaller healthcare facilities and institutions, particularly in low-to-middle-income regions. This economic strain limits the customer base primarily to well-funded urban centers, thereby creating a bottleneck that impedes the widespread adoption of essential therapeutic infrastructure.

Consequently, when healthcare providers cannot secure adequate funding or foresee a viable return on investment, the procurement of these crucial therapeutic units is often delayed or canceled, directly shrinking the total addressable market. This financial burden is compounded by declining operational revenues, making it increasingly difficult for medical centers to recover their capital investments. Uncertainty about long-term profitability compels hospitals to extend the lifespan of obsolete machinery instead of investing in new systems. For instance, in 2025, the American Society for Radiation Oncology noted a net reduction in Medicare reimbursement payments, adding to a cumulative 23% decline over the prior decade. Such fiscal instability directly hinders market growth by curtailing providers' capacity to finance the installation and complex regulatory upkeep of modern cancer treatment equipment.

Market Trends

A pivotal market trend is the expansion of Proton Therapy and Particle Beam Treatment Centers, which reflects a move towards delivering high-precision radiation with minimal exit doses, especially beneficial for pediatric and complex Central Nervous System (CNS) tumors. This trend involves building specialized facilities equipped with cyclotrons to generate charged particles, providing superior dose conformity compared to conventional photon-based systems. Healthcare networks are actively increasing their capacity to offer this treatment as a standard of care, despite the substantial infrastructural requirements.

For example, Penn Medicine broke ground on a new $224 million proton therapy center in April 2025 to enhance system-wide access to advanced particle therapy. Concurrently, the proliferation of Robotic-Assisted Surgical Oncology Platforms is transforming tumor resection by facilitating minimally invasive procedures with improved dexterity and visualization. These platforms empower surgeons to execute intricate dissections within confined anatomical areas, thereby considerably shortening postoperative recovery times and hospital stays for cancer patients. The market is experiencing a continuous rise in utilization as clinical applications extend beyond urology to encompass thoracic and general surgical oncology. Intuitive Surgical, for instance, reported approximately 20% year-over-year growth in worldwide procedures in October 2025, boosting its global installed base to 10,763 robotic systems.

Key Market Players

  • Boston Scientific Corp
  • Medtronic plc.
  • Johnson & Johnson
  • Merit Medical Inc.
  • Varian Medical Inc.
  • AngioDynamics Inc.
  • HealthTronics Inc.
  • SonaCare Medical LLC
  • Misonix Inc.
  • CAScination AG

Report Scope

In this report, the Global Tumor Treatment Equipment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Tumor Treatment Equipment Market, By Type

  • Surgical Equipment
  • Radiotherapy Equipment
  • Chemotherapy Equipment

Tumor Treatment Equipment Market, By Application

  • Lung Cancer
  • Rectal Cancer
  • Breast Cancer
  • Other

Tumor Treatment Equipment Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Tumor Treatment Equipment Market.

Available Customizations:

Global Tumor Treatment Equipment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Tumor Treatment Equipment Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Surgical Equipment, Radiotherapy Equipment, Chemotherapy Equipment)
    • 5.2.2. By Application (Lung Cancer, Rectal Cancer, Breast Cancer, Other)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Tumor Treatment Equipment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Tumor Treatment Equipment Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Tumor Treatment Equipment Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Tumor Treatment Equipment Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application

7. Europe Tumor Treatment Equipment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Tumor Treatment Equipment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
    • 7.3.2. France Tumor Treatment Equipment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Tumor Treatment Equipment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Tumor Treatment Equipment Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Tumor Treatment Equipment Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application

8. Asia Pacific Tumor Treatment Equipment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Tumor Treatment Equipment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Tumor Treatment Equipment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Tumor Treatment Equipment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Tumor Treatment Equipment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Tumor Treatment Equipment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application

9. Middle East & Africa Tumor Treatment Equipment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Tumor Treatment Equipment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Tumor Treatment Equipment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Tumor Treatment Equipment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application

10. South America Tumor Treatment Equipment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Tumor Treatment Equipment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Tumor Treatment Equipment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Tumor Treatment Equipment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Tumor Treatment Equipment Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Boston Scientific Corp
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Medtronic plc.
  • 15.3. Johnson & Johnson
  • 15.4. Merit Medical Inc.
  • 15.5. Varian Medical Inc.
  • 15.6. AngioDynamics Inc.
  • 15.7. HealthTronics Inc.
  • 15.8. SonaCare Medical LLC
  • 15.9. Misonix Inc.
  • 15.10. CAScination AG

16. Strategic Recommendations

17. About Us & Disclaimer